Financhill
Back

Lantronix, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison

Sell
42

LTRX
Lantronix, Inc.

Last Price:
$5.40
Seasonality Move:
-0.08%
Sell
46

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:
$61.04
Seasonality Move:
-2.16%
Sell
42
Lantronix, Inc. (LTRX) is a Sell

Is Lantronix, Inc. a Buy, Sell or Hold?

  • The current Lantronix, Inc. [LTRX] share price is $5.40. The Score for LTRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • LTRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $61.03. The Score for ARWR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LTRX Stock Price Chart

What is Lantronix, Inc.'s stock price today?

  • The Lantronix, Inc. share price today is $5.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LTRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARWR Stock Price Chart

What is Arrowhead Pharmaceuticals, Inc.'s stock price today?

  • The Arrowhead Pharmaceuticals, Inc. share price today is $61.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.

LTRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 43.93 Sell
Chaikin Money Flow: 297885 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.48 - 6.2) Sell
Bollinger Bands (100): (5.22 - 6.42) Sell

ARWR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 52.24 Buy
Chaikin Money Flow: -832975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.52 - 62.66) Buy
Bollinger Bands (100): (52.16 - 69.78) Buy

LTRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.49 Sell
20-day SMA: 5.81 Sell
50-day SMA: 6.02 Sell
200-day SMA: 4.89 Buy
8-day EMA: 5.45 Sell
20-day EMA: 5.68 Sell
50-day EMA: 5.84 Sell
200-day EMA: 5.09 Buy

ARWR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.99 Buy
20-day SMA: 58.47 Buy
50-day SMA: 62.54 Sell
200-day SMA: 43.35 Buy
8-day EMA: 60.24 Buy
20-day EMA: 59.83 Buy
50-day EMA: 60.7 Buy
200-day EMA: 47.94 Buy

Lantronix, Inc. Earnings Growth & LTRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.03 per share, and an increase next year of $0.16 per share.

Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.10 per share, a decrease this year of $3.21 per share, and a decrease next year of $1.06 per share.

Lantronix, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arrowhead Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):